Ophthalmology News and Research

RSS

Ophthalmology is the specialized field of medicine that focuses on the health of the eye. It includes the anatomy, physiology and diseases that may affect the eye. Historically, the science of ophthalmology encompassed all aspects of visual function, both in health and in illness. Additionally, ophthalmology also includes animal eyes as ocular function and optic diseases are similar among humans and animals.

USC to become a hub for exploring the human brain

In a rare distinction for one university, neuroimaging world leaders and USC Professors Arthur Toga and Paul Thompson will receive two major research center awards to advance their exploration of the human brain.

10 Oct 2014

Shire receives FDA guidance on regulatory path for investigational compound SHP 465

Shire plc today announced that it has received further guidance from the U.S. Food and Drug Administration on the regulatory path for SHP 465 (triple-bead mixed amphetamine salts MAS), an investigational oral stimulant medication being evaluated as a potential treatment for Attention-Deficit/Hyperactivity Disorder (ADHD) in adults.

9 Oct 2014

Surgical treatment of strabismus can be carried out at any age

Around four per cent of all newborn children have a squint. In about 50 per cent of cases, this can be corrected with appropriate glasses, however the other half require treatment for their squint and in some cases even squint surgery.

8 Oct 2014

Pitt researchers awarded $1.25 million DOD grant to establish whole-eye transplantation program

University of Pittsburgh School of Medicine researchers have been awarded $1.25 million from the U.S. Department of Defense to fund two projects that aim to establish the groundwork for the nation's first whole-eye transplantation program.

8 Oct 2014

New report shows liquid detergent pods can cause eye injuries to children

Liquid laundry and dishwasher detergent pods are an emerging source of chemical exposure in children. When squeezed or bitten into, these pods can burst and send detergent into the mouth, nose, and eyes.

8 Oct 2014

IRIDEX's new proprietary disposable delivery device granted U.S. patent

IRIDEX Corporation today announced that the United States Patent and Trademark Office granted the company a patent for a new proprietary disposable delivery device.

7 Oct 2014

Bausch + Lomb’s sub-micron loteprednol etabonate ophthalmic gel meets primary endpoint

Bausch + Lomb, a wholly owned subsidiary of Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX), today announced that its next generation sub-micron gel formulation of loteprednol etabonate was statistically superior to placebo (vehicle gel) in eliminating inflammation and pain following cataract surgery by study day eight, the primary endpoints in the first Phase 3, multi-center, double-masked, vehicle-controlled, parallel-group study.

30 Sep 2014

NIH-funded clinical trial aims to restore vision in people who have lost vision due to IIH

In an NIH-funded clinical trial, led at Saint Louis University by professor of ophthalmology Sophia Chung, M.D., researchers aim to bring sight back to those who have lost vision due to idiopathic intracranial hypertension.

29 Sep 2014

Escalon Medical announces operating results for fiscal 2014; VuPad receives CE mark authorization

Escalon Medical Corp. (NASDAQ: ESMC) today announced its operating results for the fiscal year ended September 30, 2014.

27 Sep 2014

Scientists discover new clues about drug used in treating blood cancer

Keck Medicine of USC scientists have discovered new clues about a drug instrumental in treating a certain blood cancer that may provide important targets for researchers searching for cures.

26 Sep 2014

Researchers awarded $16 million NIMH grant to create genetic resource for psychiatric disorders

A multi-institutional team of researchers studying schizophrenia and bipolar disorder has been awarded a $16 million grant from the National Institute of Mental Health to create the most extensive genetic resource to date for these two devastating psychiatric disorders, using data assembled by the University of Southern California.

26 Sep 2014

Two genes that cause pediatric glaucoma increases risk of future stroke up to ten times

Every year in Canada about 50,000 people suffer from a stroke, caused either by the interruption of blood flow or uncontrolled bleeding in the brain. While many environmental risk factors exist, including high blood pressure and smoking, stroke risk is also frequently inherited. Unfortunately, remarkably little is known regarding stroke's genetic basis.

26 Sep 2014

GuideWell, OSI partner to provide affordable, quality health care to growing Hispanic market

GuideWell Mutual Holding Corporation and Organizacion Sanitas Internacional have established a strategic alliance to create a new company with the purpose of offering a culturally relevant health delivery model that provides affordable and quality health care to the important and growing Hispanic market.

25 Sep 2014

Elsevier honored at BMA Medical Book Awards ceremony

Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today that 28 of its professional and scholarly products were honored at the British Medical Association's annual BMA Medical Book Awards ceremony at BMA House in London on Sept. 22, 2014.

25 Sep 2014

Researchers reveal why RB1 gene mutations primarily cause retinoblastomas in children

Retinoblastoma is a childhood retinal tumor usually affecting children one to two years of age. Although rare, it is the most common malignant tumor of the eye in children.

25 Sep 2014

FDA grants Breakthrough Therapy designation to EYLEA Injection for treatment of diabetic retinopathy

Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted EYLEA (aflibercept) Injection Breakthrough Therapy designation for the treatment of diabetic retinopathy in patients with diabetic macular edema (DME).

16 Sep 2014

Three-year safety data from INTREPID study of Oraya Therapy™ for wet age-related macular degeneration results announced

Oraya Therapeutics Inc. announced that full results of three-year safety follow-up data from the INTREPID study of Oraya Therapy™ for wet age-related macular degeneration (AMD) further demonstrated a favorable safety profile and also showed that there was no significant difference in vision outcomes in patients treated with Oraya Therapy compared with those receiving anti-vascular endothelial growth factor (anti-VEGF) injections alone.

15 Sep 2014

New class of compounds protect brain cells from traumatic brain injury

A new class of compounds has now been shown to protect brain cells from the type of damage caused by blast-mediated traumatic brain injury (TBI).

12 Sep 2014

Professor receives award for development of anti-angiogenic therapy for retinal disease

Napoleone Ferrara, MD, distinguished professor of pathology and distinguished adjunct professor of ophthalmology at the University of California, San Diego School of Medicine and senior deputy director for basic sciences at UC San Diego Moores Cancer Center, was named today as one of seven recipients of the Ant-nio Champalimaud Vision Award in Lisbon, Portugal.

11 Sep 2014

BioLight Life Sciences declares first sale of IOPtiMate system in Hong Kong

BioLight Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, announces the first sale of an IOPtiMate™ system in Hong Kong.

10 Sep 2014

Ophthalmology News and Research

Further Reading

USC to become a hub for exploring the human brain

Shire receives FDA guidance on regulatory path for investigational compound SHP 465

Surgical treatment of strabismus can be carried out at any age

Pitt researchers awarded $1.25 million DOD grant to establish whole-eye transplantation program

New report shows liquid detergent pods can cause eye injuries to children

IRIDEX's new proprietary disposable delivery device granted U.S. patent

Bausch + Lomb’s sub-micron loteprednol etabonate ophthalmic gel meets primary endpoint

NIH-funded clinical trial aims to restore vision in people who have lost vision due to IIH

Escalon Medical announces operating results for fiscal 2014; VuPad receives CE mark authorization

Scientists discover new clues about drug used in treating blood cancer

Researchers awarded $16 million NIMH grant to create genetic resource for psychiatric disorders

Two genes that cause pediatric glaucoma increases risk of future stroke up to ten times

GuideWell, OSI partner to provide affordable, quality health care to growing Hispanic market

Elsevier honored at BMA Medical Book Awards ceremony

Researchers reveal why RB1 gene mutations primarily cause retinoblastomas in children

FDA grants Breakthrough Therapy designation to EYLEA Injection for treatment of diabetic retinopathy

Three-year safety data from INTREPID study of Oraya Therapy™ for wet age-related macular degeneration results announced

New class of compounds protect brain cells from traumatic brain injury

Professor receives award for development of anti-angiogenic therapy for retinal disease

BioLight Life Sciences declares first sale of IOPtiMate system in Hong Kong

Event guide: The 4th Ophthalmic Drug Delivery Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News